Vytrus Biotech, S.A. (FRA:V5P)
Germany · Delayed Price · Currency is EUR 8.40
-0.15 (-1.75%)
At close: Jan 30, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €69.22 million as of January 30, 2026. Its market cap has increased by 321.10% in one year.
Market Cap
69.22M
Enterprise Value
67.36M
Revenue
8.09M
Ranking
n/a
PE Ratio
35.46
Stock Price
€8.40
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 69.22M, an increase of 350.41%. That is a compound annual growth rate of 47.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 69.22M | 7.60% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meta Wolf AG | 81.22M |
| Path2 Hydrogen AG | 78.06M |
| CGRE AG | 77.40M |
| InnoTec TSS AG | 69.38M |
| audius SE | 67.91M |
| learnd SE | 60.39M |
| WASGAU Produktions & Handels AG | 59.40M |
| Nordwest Handel AG | 58.97M |